AI assistant
Sending…
GlaxoSmithKline PLC — Director's Dealing 2017
May 31, 2017
5262_dirs_2017-05-31_54c57331-7fba-41d6-8c23-267f92d1be4e.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7494G
GlaxoSmithKline PLC
31 May 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
| 1. | Details of PDMR/person closely associated with them ('PCA') | ||||
| a) | Name | Mr R G Connor | |||
| b) | Position/status | President, Global Manufacturing & Supply | |||
| c) | Initial notification/ amendment |
Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GlaxoSmithKline plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
|||
| b) | Nature of the transaction | The transfer of 7,875 Ordinary Shares to spouse for nil consideration. | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| £0.00 | 7,875 | ||||
| d) | Aggregated information | n/a (single transaction) | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2017-05-30 | |||
| f) | Place of the transaction | n/a |
| 1. | Details of PDMR/person closely associated with them ('PCA') | ||||
| a) | Name | Mrs D Connor | |||
| b) | Position/status | PCA of Mr R G Connor (President, Global Manufacturing & Supply) | |||
| c) | Initial notification/ amendment |
Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GlaxoSmithKline plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
|||
| b) | Nature of the transaction | Receipt of 7,875 Ordinary Shares following transfer from spouse for nil consideration. | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| £0.00 | 7,875 | ||||
| d) | Aggregated information | n/a (single transaction) | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2017-05-30 | |||
| f) | Place of the transaction | n/a |
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEFLFXDEFLBBL
More from GlaxoSmithKline PLC
Report Publication Announcement
2026
May 22
Foreign Filer Report
2026
May 22
Director's Dealing
2026
May 20
Foreign Filer Report
2026
May 20
Foreign Filer Report
2026
May 20
Director's Dealing
2026
May 19
Foreign Filer Report
2026
May 19
Transaction in Own Shares
2026
May 18
Foreign Filer Report
2026
May 18
Foreign Filer Report
2026
May 18